eHealth-based Cardiac Rehabilitation in Post-myocardial Infarction Patients

Not Applicable

Recruiting

Brief Summary: The goal of this randomized controlled trial is to compare the effect of eHealth-based cardiac rehabilitation with the effect of usual care on exercise capacity and qualify of life in patients after myocardial infarction.

Detailed Description: Cardiac rehabilitation can improve exercise capacity, life of quality, readmission rate and mortality rate for patients after myocardial infarction. International guidelines list cardiac rehabilitation after myocardial infarction as class IA recommendation. However, low participation rate of cardiac rehabilitation due to barriers such as lacking of time, transport or affordability issues is an unsolved problem worldwide.

eHealth, consisting of telemedicine, mobile health and personalized care using wearable devices has the potential to remove the barriers and become an effective model to deliver cardiac rehabilitation. Thus, we design a randomized controlled trial to compare the effect of a case manager-led eHealth-based cardiac rehabilitation program with usual care on the compliance, physical activity, quality of life, and cardiorespiratory fitness in patients after myocardial infarction.

Recruitment & Eligibility

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Arm && Interventions

Group	Intervention	Description
eHealth-based cardiac rehabilitation	eHealth-based cardiac rehabilitation	Participants receive a 12-wk case manager-led eHealth-based cardiac rehabilitation program with follow-up at 12 week, 6 months and 12 months.

Primary Outcome Measures

Name	Time	Method
Change of peak oxygen uptake	at baseline, 12 weeks(post-intervention), and 12 months.	Peak oxygen uptake will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.
Change of ventilatory anaerobic threshold	at baseline, 12 weeks(post-intervention), and 12 months.	Ventilatory anaerobic threshold will be assessed using cardiopulmonary exercise test before intervention, at 12 weeks (post-intervention), and at 12 months.

Secondary Outcome Measures

Name	Time	Method
Depression	at baseline, 12 weeks(post-intervention), and 12 months.	The investigators will assess the change in Patient Health Questionnaire (PHQ-9). The PHQ-9 score ranges from 0-27. Higher scores indicate worsen symptoms.
Evaluation of grip strength	at baseline, 12 weeks(post-intervention), and 12 months.	The grip strength will be measured using a grip goniometer with the participants seated and the elbow flexed at 90 degrees.
Evaluation of isometric knee extension strength	at baseline, 12 weeks(post-intervention), and 12 months.	The isometric knee extension strength will be measured using a dynamometer with participants seated and knee flexed at 90 degrees.
Evaluation of Quality of life	at baseline, 12 weeks(post-intervention), and 12 months.	The investigators will assess the change in 36-Item Short Form Survey(SF-36).
Anxiety	at baseline, 12 weeks(post-intervention), and 12 months.	The investigators will assess the change in Generalized Anxiety Disorder scale (GAD-7). The GAD-7 score ranges 0-21. Higher scores indicate worsen symptoms.
Evaluation of physical activity	at baseline, 12 weeks(post-intervention), and 12 months.	The investigators will assess the change in physical activity using Long form International Physical Activity Questionnaire(IPAQ) Taiwan version.
Adherence to prescribed exercise	at 12 weeks(post-intervention) and 12 months.	The degree of completion of prescribed exercise will be assessed at 12 weeks and 12 months.